Newsletter

Promoting Vaccination for All Ages: The Efforts of Pfizer’s Vaccine Division

**Title: Pfizer Korea’s Vaccine Division Prioritizes Promoting Vaccination for a Healthier Future** *(Subheading) A Focus on Prevention in the Changing Medical Landscape* In today’s medical landscape, there is a growing emphasis on prevention rather than treatment, underscoring the importance of vaccines. With the advent of the COVID-19 pandemic, the awareness surrounding vaccinations has soared, leading […]

Esketamine Shows Promising Results as an Alternative Treatment for Resistant Depression: Study

Breakthrough Study Shows Esketamine as Promising Treatment for Resistant Depression Esketamine, originally an anesthetic, has demonstrated remarkable potential as a novel antidepressant, effectively combating symptoms associated with major depressive disorder. In a recent study published in the renowned international journal JAMA, renowned researchers including Chunfeng Xiao from the National Clinical Research Center for Mental Illness […]

Esketamine Shows Promising Results as Add-On Treatment for Resistant Depression

Esketamine: A Promising New Treatment for Resistant Depression A breakthrough study published in the prestigious international journal JAMA has shed light on the impressive antidepressant effects of esketamine, a drug derived from anesthesia. Led by Dr. Chunfeng Xiao of the National Clinical Research Center for Mental Illness in Beijing, China, the research highlights the potential […]

Samsung Biologics Recruits Quality Control Experts to Strengthen Competitiveness

Samsung Biologics Strengthens Quality Control Team with New Recruits Seoul, South Korea – In a bid to enhance its quality competitiveness, Samsung Biologics is stepping up its efforts by welcoming highly skilled external professionals to its quality control division. In an official announcement on the 24th, Samsung BioLogics unveiled its latest recruit, Gail Ward, who […]

The Uncertainty of Probiotics for Irritable Bowel Syndrome: Study Finds Low Evidence

Conservative Approach Recommended for Irritable Bowel Syndrome A recent study has shed light on the importance of a cautious approach when it comes to the use of probiotics in treating irritable bowel syndrome (IBD). While the microbiome hypothesis, which suggests that an imbalance of intestinal microbes can lead to various diseases, has garnered significant attention, […]

The Uncertain Effectiveness of Probiotics on Irritable Bowel Syndrome: Study Finds Conservative Approach Necessary

New Study Questions Effectiveness of Probiotics in Managing Irritable Bowel Syndrome Irritable bowel syndrome (IBS) patients looking to alleviate symptoms through probiotics may need to take a more cautious approach, according to a recent study. The microbiome hypothesis, which suggests that an imbalance of intestinal microbes leads to various diseases, has gained attention in recent […]

The Invites Precision Medical Genome Project: Revolutionizing Precision Medicine through Advanced Genomic Data Analysis

The Importance of Precision Medicine in Healthcare With advancements in technology, a reduction in treatment costs, and the utilization of medical data, precision medicine has gained significant recognition for its ability to provide tailored treatment and prevention strategies. The implementation of precision medicine is seen as the future of healthcare, emphasizing the significance of considering […]

Identification of Biomarker for Predicting Diabetic Kidney Disease Prognosis

Biomarker Identified for Predicting Diabetic Kidney Disease A breakthrough study conducted by researchers, including James L. Januzi at the prestigious Massachusetts General Hospital in the United States, has successfully identified a biomarker that can predict the onset of diabetic kidney disease. This debilitating condition, which is a result of blood vessel damage caused by diabetes, […]

Intensifying Competition between GC Green Cross and JW Pharmaceutical for the Domestic Hemophilia Treatment Market

Competition Intensifies Between GC Green Cross and JW Pharmaceutical for Hemophilia Treatment Market The battle for dominance in the domestic hemophilia treatment market is escalating between GC Green Cross and JW Pharmaceutical. GC Green Cross recently highlighted the incidence of abnormal blood clots in Hemlibra (emicizumab), a hemophilia treatment, which prompted a response from JW […]